Month: June 2013
-
AstraZeneca Acquires Respiratory Disease Therapy Developer
The global pharmaceutical company AstraZeneca is buying Pearl Therapeutics in Redwood City, California, a developer of treatments for chronic respiratory diseases. The deal is valued initially at $560 million, but has a total potential value of $1.15 billion, adding in subsequent milestone and royalty payments. The seven year-old Pearl Therapeutics develops small-molecule treatments for chronic…
-
FDA Clears Sanofi Four-Strain Flu Vaccine for Adults, Kids
Sanofi Pasteur, the vaccine division of the global pharmaceutical company Sanofi, says the Food and Drug Administration cleared for sale in the U.S. its Fluzone Quadrivalent vaccine that covers four influenza strains. The FDA action, says the company, will make the vaccine available for infants, adolescents, and adults. The Centers for Disease Control and Prevention…
-
St. Jude Medical Invests in Pain Therapy Device Developer
Medical device manufacturer St. Jude Medical in St. Paul, Minnesota is investing $40 million in pain therapy systems developer Spinal Modulation Inc. in Menlo Park, California. The equity investment deal, says St. Jude Medical, includes an option for the outright purchase of the privately-owned Spinal Modulation. Under the agreement, St. Jude Medical becomes the exclusive…
-
Dana-Farber, Foundation Partner on Expanding Clinical Trials
Dana-Farber Cancer Institute in Boston and Leukemia & Lymphoma Society (LLS) in New York are collaborating on opening new sites for clinical trials to test blood cancer therapies. LLS is investing $1,050,000 over three years in the project. The Blood Cancer Research Partnership aims to make it easier for patients to take part in clinical…
-
University Patents, Licenses Cattle Feed Supplement
Kansas State University in Manhattan received a patent and licensed a nutritional supplement for cattle feed developed by one of its faculty members. Research by animal sciences professor Jim Drouillard led to development of a supplement that improves absorption of omega-3 fatty acids beneficial to livestock, which Kansas State patented earlier this year and licensed…
-
First Bioengineered Vein Implanted for U.S. Dialysis Patient
Yesterday, a kidney dialysis patient at Duke University Hospital in Durham, North Carolina was the first in the U.S. to receive a new bioengineered blood vessel developed by a Duke University spin-off company. The patient, a 62 year-old man from Danville, Virginia with kidney failure received in his arm the engineered blood vessel made with…
-
U.K. University to Build Advanced Manufacturing Facility
University of Sheffield in the U.K. says it secured funding for an advanced manufacturing lab to study the needs of the aerospace industry and other high-value manufacturing industries. The £43 million ($US 66.3 million) lab, part of Sheffield’s Advanced Manufacturing Research Centre (AMRC), is supported by Boeing — which has its name on the official…
-
Health Organizations Form Genetics Data Standards Alliance
Some 70 health care organizations worldwide are forming an alliance to develop common standards for collecting and sharing genetic data. The organizations — representing health care providers, government agencies, academic and research institutes, foundations, and advocacy groups — seeks to create a common interoperable framework, with associated regulatory and practical guidelines, for the interchange of…
-
Non-Invasive Device Controls Robotics Devices with Thoughts
Engineers at University of Minnesota in Minneapolis developed a head cap with electrodes that captures and interprets thoughts to direct autonomous devices. The team led by biomedical engineering professor Bin He demonstrated the system with a remote-controlled flying device and published its findings yesterday in the Journal of Neural Engineering. The cap worn by the…
-
Bill Gates, VC Finance Science Collaboration Network
ResearchGate, an online network to encourage collaboration among scientists and sharing of research data, based in Berlin, closed a $35 million series C financing round, the third cycle of venture funding after start-up. The round was led by Microsoft founder Bill Gates and later-stage venture capital (VC) company Tenaya Capital. ResearchGate is a five-year old…